Imaginis - Researchers Investigate Link Between Chemotherapy and Memory Loss

Advertisement


	Researchers Investigate Link Between Chemotherapy and Memory Loss (dateline July 19, 2000)	Format for Printing

	Many breast cancer patients complain of difficulties with their abilities to remember, think, and concentrate during and after their struggles with the disease. Now researchers are beginning to investigate the cause of these cognitive problems, which many breast cancer patients have linked to chemotherapy, treatment with anti-cancer drugs. In a study published in the July issue of the Journal of Clinical Oncology, researchers say there does appear to be a link between chemotherapy and memory loss in some breast cancer patients. In their study, researchers compared 31 women with breast cancer who were receiving chemotherapy to two other groups of women: 40 breast cancer patients who had finished chemotherapy approximately two years earlier, and 36 healthy women (who had never had breast cancer or chemotherapy). The results of the study showed significantly more cognitive impairments in the 31 women who were on chemotherapy compared to the group of healthy women, regardless of mood, age, or education. Many breast cancer patients have referred to their memory loss during and after chemotherapy as �chemo fog� or �chemo brain.� Some describe it as a �dulling� of the mind. In the study, women who had been off of chemotherapy for one to two years were also seen to have more problems with language and visual-motor skills than the group of healthy women. However, not all of the women on chemotherapy (or treated with chemotherapy in the past) experienced cognitive difficulties. Though the results of the study suggest a possible link between chemotherapy and decreased cognitive function, Ian Tannock, MD, co-author of the study, says that this potential side effect should not deter breast cancer patients from considering chemotherapy. However, patients should be aware of all possible effects of chemotherapy before treatment. The risk of cognitive problems seen in this study does not outweigh the advantages of survival associated with chemotherapy that have been seen in many other studies, said Dr. Tannock. Dr. Tannock also cautions that the results of the study are preliminary and need to be confirmed in larger clinical trials . Since most of the research between chemotherapy and the mind has been focused on patients with advanced breast cancer , researchers are unsure whether chemotherapy or another aspect of the disease is to blame for memory loss in some women. While Doug Yee, MD, professor of hematology and oncology at the University of Minnesota in Minneapolis, is interested in this possible connection between chemotherapy and memory loss, he warns that it is difficult to conclude that chemotherapy is the cause of cognitive problems in breast cancer patients. Dr. Yee suggests that further research should investigate cognitive function in longtime breast cancer survivors. Researchers should also compare breast cancer patients who receive chemotherapy to women who receive surgery ( lumpectomy or mastectomy) and radiation for breast cancer. In addition, certain types of chemotherapy drugs may cause more severe memory problems than other drugs. In a 1998 study published in the Journal of the National Cancer Institute, researchers found that women who received high dose chemotherapy were more likely to experience cognitive difficulties compared with women who were given standard dose chemotherapy. If further research supports the link between chemotherapy and cognitive difficulties in some breast cancer patients, physicians may eventually develop means to specifically address this problem before chemotherapy begins or as soon as patients begin to show symptoms of memory loss. Additional Resources and References The medical report, �Cognitive Function in Breast Cancer Patients Receiving Adjuvant Chemotherapy,� is published in the July 14, 2000 issue of the Journal of Clinical Oncology. An abstract of the report is available at http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids =10894868&dopt=Abstract The July 17, 2000 Reuters Health report by Amy Norton, �Breast Cancer Chemo Linked With Memory Problems,� is available at http://www.reutershealth.com/cgi-bin/frame2?top=/tops/eline.asp &left=/elinel.asp&right= /archive/2000/07/17/eline/links/20000717elin003.asp The July 14, 2000 WebMD report by Paula Moyer, �Memory, Concentration Problems May Be Related to Chemotherapy,� is available at http://my.webmd.com/content/article/1662.50383 The medical report, �Impairment of Cognitive Function in Women Receiving Adjuvant Treatment for High-Risk Breast Cancer: High-Dose Versus Standard-Dose Chemotherapy,� is published in the February 4, 1998 issue of the Journal of the National Cancer Institute. An abstract of the report is available at http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids =9462678&dopt=Abstract To learn more about chemotherapy, please visit http://www.imaginis.com/breasthealth/chemo.asp Return to Breast Health News Archives

Imaginis.com subscribes to the HONcode principles of the Health on the Net Foundation.

Copyright © 1997-2008 Imaginis Corporation. All rights reserved. Imaginis® is a registered service mark of Imaginis Corporation, a health services company. All other trademarks and copyrights are property of their respective owners. Note: Use of this online service is subject to the disclaimer and the terms and conditions contained herein. Information found within the Imaginis.com website or in other sites linked to from Imaginis.com is provided for educational purposes only and is not intended to be used as a substitute for diagnosis and treatment by a medical doctor. Imaginis does not endorse and has no responsibility for the content of any other sites listed on Imaginis.com, and provides links and references merely as a convenience to its users. Seek immediate medical attention if your condition is urgent.